Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.13. The company has a 50 day moving average price of $0.01 and a two-hundred day moving average price of $0.02.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.